• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Self-monitoring of glucose in non-insulin dependent diabetics not linked to improved control

byJames EnglandandAnees Daud
June 16, 2017
in Chronic Disease, Endocrinology, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. In this randomized, open-label trial, glucose self-monitoring in patients with non-insulin dependent diabetes mellitus with or without electronic feedback was not associated with improved glycemic control or health related quality of life (HRQOL) at one year compared to usual care.

2. While there was short-term improvement in glycemic control in the intervention arms, it did not last at one year, and there was a significant decrease in compliance in blood glucose monitoring arms.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Type 2 diabetes mellitus remains a common and increasingly prevalent condition associated with significant morbidity and mortality. Improved glycemic control has been linked to improved clinical outcomes and is best achieved through a combination of lifestyle changes, dietary modification, and pharmacologic control. Though commonly recommended, self-monitoring of glucose in non-insulin dependent diabetics has not been conclusively shown to improve glycemic control and yet may be associated with increased health care cost and discomfort for patients. This was a randomized, open-label trial that examined the effectiveness of patient daily self-monitoring of glucose with or without electronic feedback on results compared to no monitoring. While initially both intervention groups demonstrated improved HbA1c values, there was reduced compliance by one year and no significant differences compared to control.

The primary care setting in which the trial was conducted reflected the real work setting and the randomized design improved the overall strength of the study. The main limitations included the patient exposure to endocrinologist in certain situations, and inclusion of patients with extremes of HbA1c values, both of which added extraneous variable to the study.

Click to read the study, published in JAMA Internal Medicine

Relevant Reading: Evidence of a Strong Association Between Frequency of Self-Monitoring of Blood Glucose and Hemoglobin A1c Levels in T1D Exchange Clinic Registry Participants

RELATED REPORTS

Faricimab may improve visual acuity in patients with diabetic macular edema

Supplementation of tirzepatide for type 2 diabetics on basal insulin improved glycemic control compared to placebo

Tirzepatide is superior to insulin glargine for management of type 2 diabetes and elevated cardiovascular risk

In-Depth [randomized controlled trial]: This study included patients from 15 primary care sites with a diagnosis of type 2 diabetes who were 30 years or older and had HbA1c levels at baseline between 6.5% and 9.5%. Patients were excluded if they were to be seen by an endocrinologist within one year, planned to use insulin in the study period, or were planning on moving or becoming pregnant. The main intervention included once daily glucose monitoring with an addition group having enhanced feedback with automated, encouraging messaging along with the glucose measurement. The primary outcomes included change in HbA1c levels at one year, and HRQOL as assessed by the physical and mental components of the Short Form 36 questionnaire.

A total of 450 patients were included in the study, with patients balanced with respect to age, gender, race, BMI, comorbidities, and use of hypoglycemic agents. At one year follow up there was no difference in HbA1c or HRQOL scores between the control or intervention groups. HbA1c values were lower at 6 months (p = 0.001) for both intervention groups, but were the same as control by one year. The compliance with daily glucose monitoring had fallen throughout the study in both intervention arms, dropping to 50-60% by 1 year.

Image: PD

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: blood glucosediabetes mellitus
Previous Post

Inverse relationship between level of education and risk of cardiovascular disease

Next Post

Device thrombosis more likely with bioresorbable scaffolds versus drug-eluting stents

RelatedReports

Blindness and visual impairment decreasing worldwide
Chronic Disease

Faricimab may improve visual acuity in patients with diabetic macular edema

March 8, 2022
Insulin costs rose exponentially, regardless of formulation or patent
Cardiology

Supplementation of tirzepatide for type 2 diabetics on basal insulin improved glycemic control compared to placebo

February 9, 2022
Cardiology

Tirzepatide is superior to insulin glargine for management of type 2 diabetes and elevated cardiovascular risk

January 11, 2022
#VisualAbstract: Lowering systolic blood pressure with antihypertensives may reduce new-onset type 2 diabetes
StudyGraphics

#VisualAbstract: Lowering systolic blood pressure with antihypertensives may reduce new-onset type 2 diabetes

December 2, 2021
Next Post
Radiation dose associated with increased heart disease in Hodgkin lymphoma survivors

Device thrombosis more likely with bioresorbable scaffolds versus drug-eluting stents

Blood type correlates with egg reserve in infertile women

Lipid nanoparticles deliver messenger RNA for hemophilia B protein replacement therapy [PreClinical]

Radiofrequency ablation of hepatic metastases in colorectal cancer linked with improved survival

Low-cost biochip isolates cells for clinical diagnosis [PreClinical]

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Severe actinic keratosis and need for additional treatment are markers for an increased risk of cutaneous squamous cell carcinoma
  • Virtual yoga and meditation intervention may be associated with increased health-related quality of life
  • Wellness Check: Mental Health
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.